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Disparate subcellular location of 
putative sortase substrates  
in Clostridium difficile
Johann Peltier1,2, Helen A. Shaw1,2, Brendan W. Wren2 & Neil F. Fairweather  1
Clostridium difficile is a gastrointestinal pathogen but how the bacterium colonises this niche is still 
little understood. Sortase enzymes covalently attach specific bacterial proteins to the peptidoglycan 
cell wall and are often involved in colonisation by pathogens. Here we show C. difficile proteins CD2537 
and CD3392 are functional substrates of sortase SrtB. Through manipulation of the C-terminal regions 
of these proteins we show the SPKTG motif is essential for covalent attachment to the cell wall. Two 
additional putative substrates, CD0183 which contains an SPSTG motif, and CD2768 which contains 
an SPQTG motif, are not cleaved or anchored to the cell wall by sortase. Finally, using an in vivo 
asymmetric cleavage assay, we show that despite containing a conserved SPKTG motif, in the absence 
of SrtB these proteins are localised to disparate cellular compartments.
Clostridium difficile is an intestinal pathogen that causes significant mortality and morbidity throughout the 
world1. It is the leading cause of hospital acquired diarrhoea and has become increasingly common as a commu-
nity acquired infection2. C. difficile produces two glycosylating toxins which play key roles in disease pathogen-
esis, targeting the gut epithelium resulting in severe inflammation and damage to the colon1, 3. Transmission of 
C. difficile is dependent on the production of highly resistant spores4 which germinate in the intestine. Normally 
the intestinal microbiota acts to suppress C. difficile proliferation but antibiotic treatment can modulate the host 
microbiota and can result in C. difficile growth, colonisation of the intestine and toxin production5, 6.
While details of the mechanisms and control of sporulation and toxin production are becoming increasingly 
understood, the processes involved in colonisation are still largely unclear. In many Gram-positive bacteria, sur-
face structures such as pili, flagella and exposed surface proteins are implicated in colonisation and have been 
studied is some detail. The structural organisation of the C. difficile cell wall has been investigated7, and a diversity 
of factors that may impact on intestinal colonisation by C. difficile is now recognised8.
In many Gram-positive pathogens, the activity of sortases are often important in pathogenesis9–12. Sortases are 
enzymes which catalyse the cleavage and transpeptidation of specific protein substrates facilitating their covalent 
attachment to the peptidoglycan within the cell wall13. Cleavage and transpeptidation of sortase substrates occur 
at distinct motifs within a C-terminal cell wall sorting signal (CWSS)14 containing, in the case of sortase A from 
Staphylococcus aureus, an LPXTG motif. Variations of this motif are recognised by different classes of sortases and 
vary between species15. The CWSS comprises the LPXTG motif, followed by a hydrophobic region and a short, 
positively charged tail. Sortase substrates are targeted for the Sec secretion system by their N-terminal signal 
sequence, and are retained in the secretion machinery by the C-terminal hydrophobic domain and charged tail 
allowing sortase to cleave the LPXTG motif prior to transpeptidation13.
The genome of C. difficile strain 630 has a single sortase, SrtB, and several potential substrates with a vari-
ety of “LPxTG”-like motifs. SrtB has been shown to be functional in an in vitro cell free assay with short pep-
tide substrates16–18 and to be required by C. difficile for the localisation of sortase substrates CD0386, CD2831 and 
CD324618, 19. The motifs PPKTG, SPKTG, SPSTG and SPQTG present within C. difficile sortase substrates can be 
cleaved in vitro, while the NVQTG motif of the putative sortase substrate CD3145 is not cleaved, implying this 
protein is not a true sortase substrate16, 18. Moreover, structural insights into how C. difficile sortase specifically 
recognizes the peptide substrate PPKTG have recently been provided20. The protease PPEP-1 (CD2830/Zmp1) 
has been shown to further cleave substrates CD2831 and CD3246 at a position N-terminal to the CWSS, releasing 
these proteins into the culture supernatant19, 21, 22. Cleavage by PPEP-1 has been shown to be tightly regulated 
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by c-di-GMP which regulates both PPEP-1 and CD2831 expression19, with a c-di-GMP controlled self-splicing 
ribozyme controlling CD3246 expression23. Additionally, small RNAs have been shown to control expression of 
the putative sortase substrate CD018324. The sortase substrate CD0386 is found on the conjugative transposon 
CTn1 in C. difficile 630, while its homologue CD3392 is found on CTn7, with similar genes found in transposons 
of other strains of C. difficile25. A PPEP-1mutant exhibits increased collagen binding activity, implicating sor-
tase substrates CD2831 and CD3246 in this phenotype22. Additionally, CD3246 is predicted to form an internal 
thioester bond which may be involved in binding to host proteins26.
In this study we confirm the in vivo cellular activity in C. difficile of sortase SrtB in strain 630 on substrates 
containing the motif SPKTG, while those containing SPSTG and SPQTG motifs are uncleaved and we character-
ise disparate cellular localisation phenotypes of sortase substrates.
Results
CD3392 is cell wall protein anchored by sortase. CD3392, a putative collagen binding protein, displays 
a high sequence identity of 94.38% to the known C. difficile sortase substrate CD038618. These proteins contain 
the same sorting motif, SPKTG, but otherwise the C-terminal sequences are distinct and could affect the sorting 
of this protein (Table 1). CD3392 has the classic structure of sortase substrates with an N-terminal secretion sig-
nal, and a C-terminal cell wall sorting signal (CWSS) comprising an “LPXTG” like motif, a hydrophobic region 
and a charged tail (Fig. 1A). Under laboratory conditions, CD3392 is not expressed to a level detectable by anti-
body against recombinant CD3392. The CD3392 gene was therefore expressed on plasmid pJKP036 under control 
of an anhydrotetracycline inducible promoter in C. difficile 630 and in a srtB knockout strain, ΔsrtB19. The distri-
bution of CD3392 within cytosolic, membrane and cell wall (peptidoglycan) fractions in the two strains induced 
with 100 ng/ml of ATc was studied. The cell wall fraction was generated using the purified catalytic domain of 
endolysin CD27L27 in sucrose buffer to prevent cell lysis of the protoplasts. This technique efficiently and reliably 
hydrolyses the cell wall peptidoglycan and therefore ensures complete separation of the cell wall and membrane 
fractions19. CD3392 is found in all cell compartments in the wild type 630 strain (Fig. 1B). In the ΔsrtB mutant, 
there is an increased level of CD3392 in the supernatant and a large accumulation of CD3392 in the membrane, 
demonstrating that its localisation is dependent on the activity of sortase. In the absence of sortase, the CWSS is 
not cleaved and its hydrophobic domain can therefore retain CD3392 within the membrane. Some protein that 
is not retained and passes through the membrane and is secreted into the culture supernatant. Secretion implies 
that proteins also need to cross the cell wall, and bands still observed in the cell wall fraction of the ΔsrtB mutant 
likely correspond to residual un-cleaved CD3392 retained in the cell wall in a non-covalent manner (see Fig. 2 
below). To determine whether the CWSS motif is involved in the interaction with sortase, a series of C-terminal 
deletions were expressed in wild type 630 and ΔsrtB (Fig. 1A). When the entire CWSS is deleted (ΔCWSS), 
CD3392 is found predominantly in the supernatant in both strains (Fig. 1C) showing the CWSS is necessary for 
cell association. When only the SPKTG motif is deleted (ΔSPKTG), and the hydrophobic domain and charged 
tail are retained, CD3392 is found trapped in the cell membrane fraction in both strains (Fig. 1D), mimicking the 
phenotype of the srtB knockout. These data confirm that the SPKTG motif is necessary for processing of CD3392 
by sortase and that the hydrophobic region and charged tail are required for membrane association to enable 
sorting.
The SPKTG motif of CD3392 is cleaved by sortase. As the SPKTG motif was found to be necessary 
for cell wall association, a novel asymmetric cleavage assay was designed to determine whether sortase catalyses 
cleavage of this motif in vivo. CwpV is a C. difficile surface protein which contains repeating units, falling into five 
known classes, or types, which are antigenically distinct28. Strain 630 expresses Type I CwpV repeats, therefore 
the antigenically distinct Type II CwpV repeats from strain R20352 were utilised for a cleavage assay. CD3392 was 
cloned with the addition of two Type II repeats at the C-terminus (Fig. 2A). The full length CD3392-CwpV fusion 
protein is predicted to migrate at ~125 kDa, with the cleavage fragments representing the majority of CD3392 at 
~105 kDa, and the CD3392 C-terminal region plus CwpV repeats at ~20 kDa. The CD3392-CwpV fusion protein 
was expressed in wild type 630 and in the ΔsrtB mutant. As expected, CD3392-CwpV is found substantially 
accumulated in the membrane compartment of the srtB mutant, as shown by immunoblotting with anti-CD3392 
Genea “LPxTG”b Hydrophobic domainc Charged taild
CD0183 …SPSTGKT--VSVTSINSSYYTARFVTA----- KRIL
CD2537 …SPKTGDL--GFSNSIIIFIVSSTLICLLNFNG KELKDKKDK
CD2768 …SPQTGD---VVKVTSMAPGTNYARRLITAT-- RVLG
CD2831 …PPKTGDSTTIIGEILLVIGAIVGLIVL----- RRNKNTN
CD3145 …NVQTGDQSNIMLDLALMFISLFFLIKNLTN-- KYLRRK
CD3246 …SPKTGDETQLMSYVFISVIAICGLAYQC---- KIKRN
CD0386 …SPKTGDNTNLYGLLALLLTSGAGLAGIFFY-- KRRKMKKS
CD3392 …SPKTGDSTNLMAFIVMLLVSGGGLAGTYLY--KRRKMKKS
SPA …LPETGEEN-PFIGTTVFGGLSLALGAALLAG- RRREL
Table 1. C-terminus analysis of putative sortase substrates in C. difficile. aGenes and corresponding proteins 
are from strain 630 (top) and from S. aureus Protein A (SPA); b–dthe conserved LPXTG motif (bold), the 
hydrophobic domain (underlined) and the positively charged tail (italics, bold) are indicated.
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Figure 1. The SPKTG motif is essential for processing of CD3392 by sortase. (A) Schematic representation of 
putative sortase substrate CD3392 and deletion derivatives lacking the entire cell wall sorting signal (ΔCWSS) 
or the SPKTG sorting motif (ΔSPKTG). The signal peptide (grey), mature protein (green), C-terminal sorting 
signal comprising the SPKTG motif, hydrophobic domain (black) and charged tail (+) are shown. Cleavage 
sites for signal peptidase (white arrow) and sortase (black arrow) are shown. (B–D) Cells of wild type 630 and 
the ΔsrtB mutant carrying pJKP036 expressing full length CD3392 (B), and derivatives of CD3392 lacking the 
cell wall sorting signal (pJKP051; ΔCWSS) (C) or the SPKTG sorting motif (pJKP046; ΔSPKTG) (D) were 
fractionated into supernatant (Sn), cell wall (CW), membrane (Mb) and cytoplasm (Cy) compartments. Protein 
fractions were separated by SDS-PAGE and visualised by western blot using anti-CD3392 antibody. Western 
blots were cropped for clarity; uncropped images can be found in Supplementary Fig. S1.
Figure 2. Sortase cleaves fusion protein CD3392-CwpV for cell wall attachment. (A) Schematic representation 
of CD3392-CwpV fusion protein and the predicted cleavage products. Structural domains of CD3392 are as 
in Fig. 1, with additional Type II CwpV repeats at the C-terminus (yellow). The ~125 kDa green bar represents 
uncleaved CD3392-CwpV fusion protein, while a green (~105 kDa) and yellow (~20 kDa) bars indicate 
predicted cleavage products following sortase activity. (B,C) Cells of wild type 630 and the ΔsrtB mutant 
carrying pJKP048 and expressing the CD3392-CwpV fusion protein were fractionated into supernatant (Sn), 
cell wall (CW), membrane (Mb) and cytoplasm (Cy). Protein fractions were analysed by western blot using 
antibody against CD3392 (B) or against CwpV Type II repeats (C). ◀, uncleaved CD3392-CwpV; *, large 
CD3392-CwpV cleavage product; ▷, 20 kDa fragment containing CwpV repeats. Western blots were cropped for 
clarity; uncropped images can be found in Supplementary Fig. S2.
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antibodies (Fig. 2B, black arrows), reinforcing the requirement of SrtB for translocation of CD3392 through the 
membrane. Low levels of CD3392-CwpV are observed in the membrane fraction of the wild-type strain (Fig. 2B, 
black arrows), probably because wild-type levels of SrtB are not able to cope with the artificially high levels of 
CD3392-CwpV. Faint lower molecular weight bands, that could correspond to cleaved CD3392, are also observed 
in the cell wall of wild type cells (asterisks) but are absent in the srtB mutant. To more clearly distinguish between 
the cleaved and uncleaved forms of CD3392-CwpV, the C-terminal CwpV repeats were detected using a specific 
antibody. As shown in Fig. 2C, cleaved CwpV repeats migrating at ~20 kDa can be observed predominantly in 
the membrane fraction of wild type cells. This supports the model whereby the C-terminal hydrophobic domain 
and charged tail act as a membrane anchor to enable sorting. In contrast, cleaved CwpV repeats are not detected 
in any subcellular fraction of the srtB mutant. A minor low molecular weight band can be seen in the cell wall 
fraction of the srtB mutant, but it is smaller than the species observed in wild type cells and is likely the result 
of proteolysis. Meanwhile, the high molecular weight band representing uncleaved CD3392-CwpV is observed 
in the membrane of the srtB mutant at high levels and in the membrane of the wild type cells at lower levels. 
Additionally a full length CD3392-CwpV band is observed in the cell wall of ΔsrtB, confirming the speculation 
in Fig. 1B that the species observed in the cell wall of this mutant was unprocessed CD3392. These results clearly 
confirm that sortase cleaves CD3392 for processing from the membrane onto the cell wall.
Covalent attachment of CD2537 to the cell wall is dependent on its SPKTG motif and sortase 
processing. CD2537 is the final putative sortase substrate in C. difficile 630 containing an SPKTG motif with 
the Phobius webserver predicting a weak signal peptide from residues 1 to 2029. An HA tag was added at the 
N-terminus of CD2537 between amino acids 26 and 27, and the gene was cloned under a tetracycline inducible 
promoter and introduced into wild type 630 (Fig. 3A). CD2537 was predominantly found in the cell wall, strongly 
suggesting the presence of a functional signal peptide. A similar subcellular location of CD2537 was observed 
in ΔsrtB with no accumulation in the membrane (Fig. 3B). When the entire CWSS motif was deleted, CD2537 
was found in the supernatant in both strains (Fig. 3C), suggesting that this domain is necessary for cell wall 
association. When only the SPKTG motif is deleted, CD2537 is again found associated with the cell wall in both 
wild-type and mutant strains (Fig. 3D), suggesting that the hydrophobic domain and charged tail are involved in 
association with the cell wall independently of sortase activity.
To determine whether the protein localised to the cell wall of ΔsrtB was full length CD2537 or whether fur-
ther processing occurs, CD2537 was expressed as a fusion protein with CwpV repeats at the C-terminus. A cleav-
age event is observed in both wild type 630 and ΔsrtB, with cleaved CD2537 localised to the cell wall fraction 
(Fig. 4A). However, the cleaved CwpV fragment migrates at a larger size in ΔsrtB compared with wild type cells 
(Fig. 4B), which suggests that an alternative cleavage event can occur in the absence of sortase to release CD2537 
Figure 3. CD2537 cell wall association can occur independently of sortase activity. (A) Schematic of putative 
sortase substrate CD2537HA protein and predicted cleavage sites with derivatives indicated by bars. Wild type 
630 and the ΔsrtB mutant carrying pJKP064 expressing full length CD2537HA (B), and derivatives lacking 
the cell wall sorting signal (pJKP071; ΔCWSS) (C), or the SPKTG sorting motif (pJKP072; ΔSPKTG) (D) 
were fractionated into supernatant (Sn), cell wall (CW), membrane (Mb) and cytoplasm (Cy) compartments. 
Proteins were visualised by western blot with anti-HA tag antibody. Western blots were cropped for clarity; 
uncropped images can be found in Supplementary Fig. S3.
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from the membrane. The size of this fragment suggests that a site upstream of the SPKTG motif may be recog-
nised by another enzyme to release CD2537 from the membrane in the absence of sortase.
The cell wall extraction method utilised releases all proteins external to the cytoplasmic membrane, including 
non-covalently anchored proteins such as the S-layer proteins. To assess whether CD2537 is covalently associated 
with the cell wall fraction, peptidoglycan was purified from wild type 630 and the srtB mutant with only cova-
lently linked molecules retained, and a dot blot undertaken to detect CD2537. Figure 4C shows that in wild type 
cells CD2537 is found in the pure peptidoglycan fraction, whereas it is absent from this fraction in ΔsrtB. When 
the SPKTG motif is deleted from CD2537, the protein is not found covalently attached to the peptidoglycan in 
either strain. This shows that CD2537 is covalently anchored to the cell wall by sortase through its SPKTG motif, 
but in the absence of sortase it can associate with the cell wall in a non-covalent manner by an alternative pro-
cessing reaction.
CD0183 and CD2768 are not processed by sortase in C. difficile. Previous studies have shown that, 
in vitro, SPKTG and SPSTG motifs are cleaved by sortase with comparable efficiency16. To determine whether the 
SPSTG motif is utilised by sortase in vivo, we investigated the localisation of CD0183 in C. difficile. Expression 
levels of CD0183 in C. difficile 630 are sufficient to detect efficiently by immunoblotting. In both wild type 630 and 
ΔsrtB, CD0183 is observed principally in the culture supernatant with a minor band detectable in the cell wall 
(Fig. 5A), suggesting either that CD0183 is not processed by sortase, or it is further processed from the cell wall as 
seen with CD2831 and CD324619. To determine whether further processing was occurring, CD0183 was cloned 
on a plasmid with two type II CwpV repeats at its C-terminus and cleavage of this fusion protein was analysed. As 
shown in Fig. 5B, uncleaved CD0183-CwpV is detected in the culture supernatant and cell wall in both wild type 
630 and ΔsrtB, with no evidence of cleavage products. This shows that despite the ability of sortase to cleave the 
SPSTG motif in vitro, this motif in CD0183 is not processed by sortase in C. difficile cells.
The last putative sortase substrate, CD2768, harbours an SPQTG motif, which has been shown to be cleaved in 
vitro with greater efficiency than the SPKTG motif16. Since no antibody against CD2768 was available, a derivative 
of CD2768 with an HA-tag inserted immediately C terminal of its signal peptide was constructed on a plasmid 
under control of the anhydrotetracycline promoter. Upon induction, HA-CD2768 is detected by Western blot and 
exclusively observed in the culture supernatant of both wild type and ΔsrtB strains (Fig. 5C). This result strongly 
suggests that, as with CD0183, this protein is not processed by sortase.
Figure 4. Sortase covalently anchors CD2537 to the peptidoglycan. Cells of wild type 630 and the ΔsrtB 
mutant expressing plasmid-encoded CD2537HA-CwpV fusion protein were fractionated into supernatant (Sp), 
cell wall (CW), membrane (Mb) and cytoplasm (Cy) compartments. Protein fractions were analysed by western 
blot using anti-HA antibody (A) or anti-CwpV Type II repeats antibody (B). Peptidoglycan fractions were 
purified from wild type 630 and the ΔsrtB mutant expressing full length CD2537HA or its ΔSPKTG derivative 
and analysed by dot blot with anti-HA tag antibodies to detect the presence of CD2537 covalently anchored to 
peptidoglycan (C). Western blots were cropped for clarity; uncropped images can be found in Supplementary 
Fig. S4.
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Discussion
The genome of C. difficile strain 630 contains a single functional sortase enzyme (SrtB) and eight potential sor-
tase substrates containing a variety of sorting motifs16; (Table 1). Of these substrates, only CD0386, CD2831 and 
CD3246 have been shown to be processed by SrtB in vivo18, 19 and the collagen binding protein CD3145 (CbpA) 
is not processed by sortase in vitro, suggesting it is not a true substrate in vivo16, 18, 30. Additionally, surface locali-
sation of CD2831 and CD3246 is further modulated by the activity of the proteolytic activity of PPEP-1 that can 
release attached proteins from the cell wall in a process regulated by cyclic-di GMP19, 21, 22. Thus, expression of 
sortase and the presence of a CWSS in a surface protein is clearly not sufficient to localise substrates to the cell 
wall in C. difficile. This situation prompted us to investigate further sortase substrates to characterise their cellular 
localisation.
We chose to study the substrates CD3392 and CD2537, both containing an SPKTG sorting motif. With the 
aid of protein modifications, we show that CD3392 displays a classical “sorted” phenotype; that of being cell 
wall attached in the presence of sortase but accumulated in the membrane in the absence of a functional sor-
tase enzyme. However, it was somewhat surprising that the total levels of CD3392 observed in the wild type 
strain were much lower than those found in the sortase mutant. In the wild type strain, we would have expected 
increased amounts of CD3392 to be present at the cell surface, but we did not observe this. This may suggest that 
extensive degradation of CD3392 by unknown proteases may occur once it localised at the cell surface.
CD2537 was found covalently anchored to the peptidoglycan through the activity of SrtB, yet we also found 
CD2537 still able to associate with the cell wall in the absence of sortase, however, this association was shown 
to be non-covalent. Some sortase substrates have previously been shown to associate at low levels with cells in 
sortase mutants, for example the GamR protein of Bacillus anthracis associates with cells during peptidoglycan 
purification until the final stages when it is absent from the pure peptidoglycan fraction31. It is interesting to 
note that this processing towards a non-covalent interaction does not seem to occur in wild-type C. difficile 630 
expressing sortase. This may be due to protection from proteomic “shaving” as observed with the B. subtilis sor-
tase substrate YfkN which is only significantly released from the cells in the absence of sortase32 or may just be a 
result of protein degradation from the secretion machinery. It remains to be determined which, if any, enzyme is 
Figure 5. CD0183 and CD2768 are not anchored to the peptidoglycan by sortase in C. difficile. Cells of wild 
type 630 and the ΔsrtB mutant without plasmid (A), expressing plasmid encoded CD0183-CwpV fusion 
protein (pHAS039) (B), or plasmid encoded CD2768HA (pJKP077) (C) were fractionated into supernatant 
(Sn), cell wall (CW), membrane (Mb) and cytoplasm (Cy) compartments. Protein fractions were analysed by 
western blot using anti-0183 antibody (A), anti-CwpV antibody (B), or anti-HA tag antibody (C). ◀, uncleaved 
CD0183-CwpV; ◁, size of expected fragment containing CwpV repeats. Western blots were cropped for clarity; 
uncropped images can be found in Supplementary Fig. S5.
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capable of processing membrane bound CD2537. Our results show that the localisation phenotype in C. difficile 
in the absence of sortase varies for each sortase substrate, even within the subset of SPKTG motif proteins (Fig. 6).
Despite C. difficile SrtB being able to cleave in vitro synthetic peptides bearing SPSTG and SPQTG motifs, 
CD0183 and CD2768, which harbour these two motifs respectively, do not appear to be cell wall anchored. 
Moreover, full length CD0183 protein fused to CwpV repeats was not processed in C. difficile cells. A common 
feature between CD0183 and CD2768 is that they contain a weakly hydrophobic C-terminal domain and have 
a short positively charged tail (Table 1). Since the function of these two elements is to delay secretion across the 
membrane and facilitate processing by sortase13, it is possible that the proteins are not retained long enough for 
sortase processing. In Staphylococcus aureus, protein A (Spa) is predominantly anchored to the cell surface by 
sortase A but a significant proportion of this protein is also released in the culture supernatant33. It was recently 
shown that, after its covalent anchoring to peptidoglycan, Spa protein together with linked peptidoglycan frag-
ments can be shed from the cell surface into the extracellular medium by the peptidoglycan hydrolase LytM. 
Therefore, Spa released by this mechanism is firstly processed by SrtA to be covalently anchored to peptidoglycan 
and subsequently released into the supernatant. In addition, full length Spa protein with an unprocessed sorting 
signal has also been observed in the culture supernatant34. Replacing the Spa sorting signal with the sorting signal 
of another SrtA substrate, SrdE, reduces the amount of Spa released, demonstrating that release of a sortase sub-
strate depends on the sequence of its sorting signal.
The data presented here shed light on the nature of proteins recognized by sortase in C. difficile. Despite our 
detailed knowledge of the mechanism of sortase cleavage, our knowledge of the role of sortase in C. difficile is 
in its infancy, particularly with regards to pathogenesis as published studies have only reported on the hamster 
model of pathogenic, toxigenic infection18. Sortase is known to act on protein CD2831 to mediate surface locali-
sation, which may facilitate adhesion to substrates in the intestinal tract21, 22. This surface attachment is regulated 
by the protease activity of PEEP-1, which is under the control of cyclic di-GMP. Further knowledge of the activ-
ities of the sortase substrates combined with in vivo experiments using relevant animal models such as colonisa-
tion will throw light on the role(s) of sortase and its substrates during infection.
In conclusion, it is clear that possession of a sortase CWSS does not necessarily result in permanent cova-
lent attachment of proteins to the Gram-positive cell wall, even when cleavage activity is observed in vitro. 
Furthermore, as shown by several studies19, 33, 34, release of sorted proteins from the cell wall appears to be a strat-
egy used by several species to present proteins either on the cell surface or in the supernatant.
Experimental Procedures
Strains, plasmids and growth conditions. C. difficile 63035 and a previously constructed ΔsrtB mutant19 
were grown under anaerobic conditions (80% N2, 10% CO2, 10% H2) in an anaerobic incubator (Don Whitley 
Scientific) at 37 °C on Brain Heart Infusion Supplemented (BHIS) plates or in broth [BHI supplemented with 5 g/l 
yeast extract (BD Bacto), and 1 g/l L-cysteine, and 15 g/l agar (Bacto) for plates]. Growth was supplemented with 
thiamphenicol (15 μg/ml) for plasmid propagation, cycloserine (250 μg/ml) and cefoxitin (25 μg/ml) for counter 
selection against E. coli during conjugation, and anhydrotetracycline (ATc 100 ng/ml) for induction of Ptet expres-
sion vectors36. Escherichia coli NEB5α (New England Biolabs) was used for cloning and plasmid propagation, 
Figure 6. SPKTG sortase substrate processing in C. difficile. A functional model of sortase substrate processing 
to the cell wall of C. difficile. The surface of C. difficile is comprised of a thick peptidoglycan cell wall (bars), 
secondary cell wall polymers (not shown) and an external, non-covalently attached S-layer comprised of S-layer 
protein SlpA (grey and red) and an assortment of minor cell wall proteins (CWPs). Sortase (purple) is shown 
at the membrane adjacent to a peptidoglycan anchored sortase substrate (1). Through degradation or release 
by unknown proteases (orange) or non-specific proteolysis, some un-sorted substrates as seen with CD2537 
in the absence of sortase are released from the membrane and are non-covalently associated with the cell wall 
(2). CD3392 remains predominantly anchored in the membrane if sortase is not available to covalently attach it 
to the cell wall (3). Proteases such as PPEP-1 (green) are able to cleave sortase substrates CD2831 and CD3246 
from the cell wall for release into the supernatant (4).
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 9204  | DOI:10.1038/s41598-017-08322-1
strain CA434 (HB101 carrying R702) was used for conjugation of plasmids into C. difficile, and Rosetta (Novagen, 
carrying pRARE) was used for expression of proteins for purification. E. coli strains were grown on LB agar and 
in LB broth supplemented with chloramphenicol (15 μg/ml) and kanamycin (50 μg/ml).
Construction of plasmids. Plasmids and oligonucleotides are listed in Table S1 and were constructed using 
standard methods. For expression of recombinant CD0183 (residues 25–291) and CD3392 (residues 30–294), 
primers NF1612 with NF1613 and NF1616 with NF1617 respectively were used to PCR-amplify the correspond-
ing DNA sequence. Purified PCR products were digested with NcoI and XhoI and ligated into the pET28a vector 
digested with the same enzymes, yielding pHAS026 and pHAS028. These pET28a plasmids were initially trans-
formed into E. coli strain NEB5α and sequences verified prior to transformation into E. coli strain Rosetta for 
protein expression and purification.
To introduce CwpV repeats at the C-terminus of CD0183, primers NF1785 and NF1817 were paired to 
amplify the entire coding sequence of CD0183 and its ribosome binding site without its gene stop codon from 
630 genomic DNA and include an XhoI site for insertion of CwpV repeats between XhoI and BamHI sites. 
Purified PCR product was digested with SacI and BamHI and ligated into pRPF185 to create pHAS037. CwpV 
was PCR-amplified from R20352 genomic DNA by primers NF1818 and NF1799, and the purified PCR product 
was digested with XhoI and BamHI for ligation into pHAS037, yielding pHAS039.
The entire coding sequence of CD2537 and its ribosome binding site were amplified from 630 genomic DNA 
with primers NF2643 and NF2288, digested with SacI and BamHI and ligated into pRPF185 to create pJKP053. 
To introduce an hemagluttinin epitope tag (HA-tag) into CD2537, plasmid pJKP053 was then modified by inverse 
PCR with oligonucleotides NF2722 and NF2723, containing an appended sequence encoding for the HA tag, 
yielding pJKP064. The HA-tag was introduced downstream of the signal peptide. To remove the SPKTG motif 
from CD2537, primers NF2855 and NF2856 were paired for inverse PCR from pJKP064 to create pJKP071. To 
remove the entire cell wall sorting motif from CD2537, primers NF2855 and NF2857 were paired for inverse PCR 
from pJKP064 to create pJKP072. To introduce CwpV repeats at the C-terminus of CD2537, primers NF2643 and 
NF2863 were paired to amplify the entire coding sequence of HA-CD2537 and its ribosome binding site with-
out its gene stop codon from pJKP064. Purified PCR product was digested with SacI and XhoI and ligated into 
pHAS039 backbone digested with the same enzymes to create pJKP074.
The entire coding sequence of CD2768 and its ribosome binding site were amplified from 630 genomic DNA 
with primers NF2883 and NF2884, digested with SacI and BamHI and ligated into pRPF185 to create pJKP075. 
To introduce an hemagluttinin epitope tag (HA-tag) into CD2768, plasmid pJKP075 was then modified by inverse 
PCR with oligonucleotides NF2887 and NF2888, containing an appended sequence encoding for the HA tag, 
yielding pJKP077. The HA-tag was introduced downstream of the signal peptide.
The entire coding sequence of CD3392 and its ribosome binding site were amplified from 630 genomic DNA 
with primers NF2378 and NF2379, digested with SacI and BamHI and ligated into pRPF185 to create pJKP036. To 
remove the SPKTG motif from CD3392, primers NF1648 and NF2582 were paired for inverse PCR from pJKP036 
to create pJKP046. To remove the entire cell wall sorting motif from CD3392, primers NF2581 and NF2582 
were paired for inverse PCR from pJKP036 to create pJKP051. To introduce CwpV repeats at the C-terminus 
of CD3392, primers NF2134 and NF2135 were paired to amplify the entire coding sequence of CD3392 and its 
ribosome binding site without its gene stop codon from pJKP036. Purified PCR product was digested with SacI 
and XhoI and ligated into pHAS039 backbone digested with the same enzymes to create pJKP048.
Purification of recombinant CD0183 and CD3392 protein and generation of antibodies. Protein 
expression was induced in E. coli Rosetta using OverNight Express Instant TB medium (Merck). Recombinant 
proteins were purified by affinity chromatography in a HisTrap chelating HP column (GE Healthcare) on an 
AKTA liquid chromatography system (Pharmacia). Purified CD0183 and CD3392 protein were injected into 
BALB/c mice together with Freund’s incomplete adjuvant to raise polyclonal antibodies.
Preparation and analysis of cell extracts. Whole cell lysates of C. difficile were prepared as previously 
described36. Briefly, cultures were harvested by centrifugation at 4,000 × g for 10 min at 4 °C and the pellets were 
frozen at −20 °C. Cells were thawed, resuspended in PBS containing 40 μg/ml DNase I to an A600 nm of 20, and 
incubated at 37 °C for 40 min. Culture supernatants were filtered with a 0.22-μm filter and precipitated on ice with 
10% TCA for 30 min. Precipitates were harvested at 25,000 × g for 10 min at 4 °C, and the pellet was washed twice 
in ice-cold 90% acetone for 10 min. The pellet was finally resuspended in PBS to an A600 nm of 20. Cell wall proteins 
were extracted as previously described19. Briefly, C. difficile cultures were harvested by centrifugation at 4,000 × g 
for 2 min, resuspended in phosphate-sucrose buffer (0.05 M HNa2PO4, pH 7.0, 0.5 M sucrose) to an A600 nm  
of 20 with 30 μg/ml purified CD27L endolysin19, and incubated at 37 °C for 1 h. Protoplasts were recovered by 
centrifugation at 6000 × g for 20 min at 4 °C. Supernatants containing the cell wall (CW) fraction were removed, 
and the protoplast pellet was lysed with resuspension in phosphate buffer (0.05 M HNa2PO4, pH 7.0) containing 
40 μg/ml DNase I at an A600 nm of 50 and incubated at 37 °C for 45 min. Lysates were harvested at 25,000 × g for 
10 min at 4 °C, supernatants containing the cytoplasmic (Cy) fraction were removed, and the membrane pellet 
was resuspended in phosphate buffer with 1% SDS at an A600 nm of 20. For analysis by SDS-PAGE, an equal volume 
of 2 × SDS sample buffer was added to protein samples. SDS-PAGE and Western immunoblotting were carried 
out using standard methods.
Peptidoglycan purification. Cultures of C. difficile were harvested by centrifugation at 5000 × g for 10 min 
at 4 °C and the pellets were resuspended in PBS to an A600 nm of 40. Cells were lyzed through 3 passages in French 
press and cell lysates were centrifuged at 25000 × g for 20 min at 4 °C. The pellets were then resuspended in 
PBS containing 1% SDS to an A600 nm of 40 and the suspensions were boiled for 15 min. After centrifugation at 
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25000 × g for 20 min at room temperature, the pellets were resuspended again in PBS containing 1% SDS to an 
A600 nm of 40 and boiled for 10 min. After centrifugation at 25000 × g for 20 min at room temperature, the pellet 
was washed twice with PBS and finally resuspended in PBS to an A600 nm of 40. The suspension contains purified 
peptidoglycan and its covalently-attached molecules. Peptidoglycan fractions were analysed by dot-blot using a 
Bio-Dot apparatus (Biorad).
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